Charlotte Servais

408 citations
12 papers · 340 indexed · h-index 8
Topics
Virus-based gene therapy research (3 papers)CAR-T cell therapy research (3 papers)Gut microbiota and health (3 papers)
Partner nations
ItalyIsraelBelgium

In The Last Decade

Charlotte Servais

11 papers receiving 337 citations

Peers

Charlotte Servais
Comparison fields: 5 of 55
  • Oncology 233
  • Immunology 129
  • Molecular Biology 122
  • Cancer Research 66
  • Genetics 30
Replace Martina Musella with:
Martina Musella Italy
Annelisa M. Cornel Netherlands
Ran Yan United States
Christopher D. Zahm United States
Andrea Walens United States
Ivana Heřmanová Czechia
Faten El Hage France
B. Florien Westendorp Netherlands
Susan K. Rathe United States
Shahrokh Abdolahi Iran
Charlotte Servais relative to Martina Musella Italy Martina Musella's profile →
Citations per field
00.5×10.7×
Martina Musella · 1×
Citations per year

Countries citing papers authored by Charlotte Servais

Since Specialization
Citations

This map shows the geographic impact of Charlotte Servais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte Servais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte Servais more than expected).

Fields of papers citing papers by Charlotte Servais

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotte Servais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte Servais. The network helps show where Charlotte Servais may publish in the future.

Co-authorship network of co-authors of Charlotte Servais

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotte Servais. A scholar is included among the top collaborators of Charlotte Servais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotte Servais. Charlotte Servais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 0
2 3
3 1
4 1
5 7
6 57
7 30
8 86
9 132
10 8
11 8
12 7

About Charlotte Servais

Charlotte Servais is a scholar working on Biotechnology, Oncology and Clinical Biochemistry, having authored 12 papers that have together received 340 indexed citations. Recurring topics across this work include Virus-based gene therapy research (3 papers), CAR-T cell therapy research (3 papers) and Gut microbiota and health (3 papers). The work is most often cited by research in Oncology (233 citations), Immunology (129 citations) and Cancer Research (66 citations). Charlotte Servais has collaborated with scholars based in Italy, Israel and Belgium. Frequent co-authors include Neta Erez, Yoray Sharon, Ron Lavy, Tova Waks, Hinrich Abken, Zelig Eshhar, Markus Chmielewski, Peter Altevogt, Annick Brandenburger and Thierry Velu. Their work appears in journals such as Gastroenterology, The Journal of Infectious Diseases and The Journal of Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026